LymphedemaV1, PubMed, Checkpoint, bibRecord, 007A77

[Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].

Identifieur interne : 007A77 ( PubMed/Checkpoint ); précédent : 007A76; suivant : 007A78

[Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].

Auteurs : P. Cusumano [Belgique] ; V. Bleret ; C. Nos ; R. Hustinx ; H. Lilet ; P. Gomez ; E. Lifrange

Source :

Revue medicale de Liege [ 0370-629X ]

RBID : pubmed:21826973

Descripteurs français

KwdFr :
- Aisselle, Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Lymphadénectomie, Noeuds lymphatiques (anatomopathologie), Tumeurs du sein (anatomopathologie).
MESH :
- anatomopathologie : Noeuds lymphatiques, Tumeurs du sein.
- Aisselle, Biopsie de noeud lymphatique sentinelle, Femelle, Humains, Lymphadénectomie.

English descriptors

KwdEn :
- Axilla, Breast Neoplasms (pathology), Female, Humans, Lymph Node Excision, Lymph Nodes (pathology), Sentinel Lymph Node Biopsy.
MESH :
- pathology : Breast Neoplasms, Lymph Nodes.
- Axilla, Female, Humans, Lymph Node Excision, Sentinel Lymph Node Biopsy.

Abstract

The status of the axillary lymph nodes is one of the most important prognostic factors in women with early stage breast cancer. Histologic examination of removed lymph nodes is the most accurate method for assessing spread of disease to these nodes. Axillary lymph node dissection (ALND) remains the standard approach for women who have clinically palpable axillary nodes. The benefits of ALND include its impact on disease control (axillary recurrence and survival), its prognostic value, and its role in treatment selection. However, the anatomic disruption caused by ALND may result in lymphedema, nerve injury, and shoulder dysfunction, which compromise functionality and quality of life. For patients who have clinically negative axillary lymph nodes, sentinel lymph node (SLN) biopsy offers a less morbid method to determine if there are positive nodes, in which case axillary node dissection would be necessary. Patients who are SLN-positive should undergo complete ALND. Axillary reverse mapping (ARM) is a recent improvement of ALND which, like the biopsy of the GS, would reduce morbidity.

PubMed: 21826973

Affiliations:

Belgique

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002490
to stream PubMed, to step Curation: 002490

Links to Exploration step

pubmed:21826973

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].</title>
<author><name sortKey="Cusumano, P" sort="Cusumano, P" uniqKey="Cusumano P" first="P" last="Cusumano">P. Cusumano</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de Sénologie, CHU de Liège, Belgique. gcusumano@chu.ulg.ac.be</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Service de Sénologie, CHU de Liège</wicri:regionArea>
<wicri:noRegion>CHU de Liège</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bleret, V" sort="Bleret, V" uniqKey="Bleret V" first="V" last="Bleret">V. Bleret</name>
</author>
<author><name sortKey="Nos, C" sort="Nos, C" uniqKey="Nos C" first="C" last="Nos">C. Nos</name>
</author>
<author><name sortKey="Hustinx, R" sort="Hustinx, R" uniqKey="Hustinx R" first="R" last="Hustinx">R. Hustinx</name>
</author>
<author><name sortKey="Lilet, H" sort="Lilet, H" uniqKey="Lilet H" first="H" last="Lilet">H. Lilet</name>
</author>
<author><name sortKey="Gomez, P" sort="Gomez, P" uniqKey="Gomez P" first="P" last="Gomez">P. Gomez</name>
</author>
<author><name sortKey="Lifrange, E" sort="Lifrange, E" uniqKey="Lifrange E" first="E" last="Lifrange">E. Lifrange</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="????"><PubDate><MedlineDate>2011 May-Jun</MedlineDate>
</PubDate>
</date>
<idno type="RBID">pubmed:21826973</idno>
<idno type="pmid">21826973</idno>
<idno type="wicri:Area/PubMed/Corpus">002490</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002490</idno>
<idno type="wicri:Area/PubMed/Curation">002490</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002490</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002490</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002490</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].</title>
<author><name sortKey="Cusumano, P" sort="Cusumano, P" uniqKey="Cusumano P" first="P" last="Cusumano">P. Cusumano</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de Sénologie, CHU de Liège, Belgique. gcusumano@chu.ulg.ac.be</nlm:affiliation>
<country xml:lang="fr">Belgique</country>
<wicri:regionArea>Service de Sénologie, CHU de Liège</wicri:regionArea>
<wicri:noRegion>CHU de Liège</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Bleret, V" sort="Bleret, V" uniqKey="Bleret V" first="V" last="Bleret">V. Bleret</name>
</author>
<author><name sortKey="Nos, C" sort="Nos, C" uniqKey="Nos C" first="C" last="Nos">C. Nos</name>
</author>
<author><name sortKey="Hustinx, R" sort="Hustinx, R" uniqKey="Hustinx R" first="R" last="Hustinx">R. Hustinx</name>
</author>
<author><name sortKey="Lilet, H" sort="Lilet, H" uniqKey="Lilet H" first="H" last="Lilet">H. Lilet</name>
</author>
<author><name sortKey="Gomez, P" sort="Gomez, P" uniqKey="Gomez P" first="P" last="Gomez">P. Gomez</name>
</author>
<author><name sortKey="Lifrange, E" sort="Lifrange, E" uniqKey="Lifrange E" first="E" last="Lifrange">E. Lifrange</name>
</author>
</analytic>
<series><title level="j">Revue medicale de Liege</title>
<idno type="ISSN">0370-629X</idno>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Axilla</term>
<term>Breast Neoplasms (pathology)</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Lymph Nodes (pathology)</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Aisselle</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
<term>Noeuds lymphatiques (anatomopathologie)</term>
<term>Tumeurs du sein (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Noeuds lymphatiques</term>
<term>Tumeurs du sein</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Breast Neoplasms</term>
<term>Lymph Nodes</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Axilla</term>
<term>Female</term>
<term>Humans</term>
<term>Lymph Node Excision</term>
<term>Sentinel Lymph Node Biopsy</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Aisselle</term>
<term>Biopsie de noeud lymphatique sentinelle</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lymphadénectomie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The status of the axillary lymph nodes is one of the most important prognostic factors in women with early stage breast cancer. Histologic examination of removed lymph nodes is the most accurate method for assessing spread of disease to these nodes. Axillary lymph node dissection (ALND) remains the standard approach for women who have clinically palpable axillary nodes. The benefits of ALND include its impact on disease control (axillary recurrence and survival), its prognostic value, and its role in treatment selection. However, the anatomic disruption caused by ALND may result in lymphedema, nerve injury, and shoulder dysfunction, which compromise functionality and quality of life. For patients who have clinically negative axillary lymph nodes, sentinel lymph node (SLN) biopsy offers a less morbid method to determine if there are positive nodes, in which case axillary node dissection would be necessary. Patients who are SLN-positive should undergo complete ALND. Axillary reverse mapping (ARM) is a recent improvement of ALND which, like the biopsy of the GS, would reduce morbidity.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">21826973</PMID>
<DateCreated><Year>2011</Year>
<Month>08</Month>
<Day>10</Day>
</DateCreated>
<DateCompleted><Year>2011</Year>
<Month>09</Month>
<Day>27</Day>
</DateCompleted>
<DateRevised><Year>2015</Year>
<Month>08</Month>
<Day>26</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0370-629X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>66</Volume>
<Issue>5-6</Issue>
<PubDate><MedlineDate>2011 May-Jun</MedlineDate>
</PubDate>
</JournalIssue>
<Title>Revue medicale de Liege</Title>
<ISOAbbreviation>Rev Med Liege</ISOAbbreviation>
</Journal>
<ArticleTitle>[Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].</ArticleTitle>
<Pagination><MedlinePgn>336-40</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The status of the axillary lymph nodes is one of the most important prognostic factors in women with early stage breast cancer. Histologic examination of removed lymph nodes is the most accurate method for assessing spread of disease to these nodes. Axillary lymph node dissection (ALND) remains the standard approach for women who have clinically palpable axillary nodes. The benefits of ALND include its impact on disease control (axillary recurrence and survival), its prognostic value, and its role in treatment selection. However, the anatomic disruption caused by ALND may result in lymphedema, nerve injury, and shoulder dysfunction, which compromise functionality and quality of life. For patients who have clinically negative axillary lymph nodes, sentinel lymph node (SLN) biopsy offers a less morbid method to determine if there are positive nodes, in which case axillary node dissection would be necessary. Patients who are SLN-positive should undergo complete ALND. Axillary reverse mapping (ARM) is a recent improvement of ALND which, like the biopsy of the GS, would reduce morbidity.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cusumano</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
<AffiliationInfo><Affiliation>Service de Sénologie, CHU de Liège, Belgique. gcusumano@chu.ulg.ac.be</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bleret</LastName>
<ForeName>V</ForeName>
<Initials>V</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nos</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Hustinx</LastName>
<ForeName>R</ForeName>
<Initials>R</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lilet</LastName>
<ForeName>H</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Gomez</LastName>
<ForeName>P</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y"><LastName>Lifrange</LastName>
<ForeName>E</ForeName>
<Initials>E</Initials>
</Author>
</AuthorList>
<Language>fre</Language>
<PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<VernacularTitle>Ganglion sentinelle et sentibras: pour un "staging" axillaire sur mesure.</VernacularTitle>
</Article>
<MedlineJournalInfo><Country>Belgium</Country>
<MedlineTA>Rev Med Liege</MedlineTA>
<NlmUniqueID>0404317</NlmUniqueID>
<ISSNLinking>0370-629X</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D001365" MajorTopicYN="N">Axilla</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008197" MajorTopicYN="N">Lymph Node Excision</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008198" MajorTopicYN="N">Lymph Nodes</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="Y">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D021701" MajorTopicYN="Y">Sentinel Lymph Node Biopsy</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2011</Year>
<Month>8</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2011</Year>
<Month>8</Month>
<Day>11</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2011</Year>
<Month>9</Month>
<Day>29</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">21826973</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Belgique</li>
</country>
</list>
<tree><noCountry><name sortKey="Bleret, V" sort="Bleret, V" uniqKey="Bleret V" first="V" last="Bleret">V. Bleret</name>
<name sortKey="Gomez, P" sort="Gomez, P" uniqKey="Gomez P" first="P" last="Gomez">P. Gomez</name>
<name sortKey="Hustinx, R" sort="Hustinx, R" uniqKey="Hustinx R" first="R" last="Hustinx">R. Hustinx</name>
<name sortKey="Lifrange, E" sort="Lifrange, E" uniqKey="Lifrange E" first="E" last="Lifrange">E. Lifrange</name>
<name sortKey="Lilet, H" sort="Lilet, H" uniqKey="Lilet H" first="H" last="Lilet">H. Lilet</name>
<name sortKey="Nos, C" sort="Nos, C" uniqKey="Nos C" first="C" last="Nos">C. Nos</name>
</noCountry>
<country name="Belgique"><noRegion><name sortKey="Cusumano, P" sort="Cusumano, P" uniqKey="Cusumano P" first="P" last="Cusumano">P. Cusumano</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Checkpoint

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 007A77 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 007A77 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:21826973
   |texte=   [Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:21826973" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème

[Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].

[Sentinel lymph node biopsy and axillary reverse mapping: a tailoring axillary staging in breast cancer].

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki